229 related articles for article (PubMed ID: 25119986)
1. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting.
Kwon T; Jeong IG; Lee J; Lee C; You D; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2015 Jan; 141(1):169-76. PubMed ID: 25119986
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162
[TBL] [Abstract][Full Text] [Related]
6. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.
Pak S; You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Kim CS; Ahn H
Sci Rep; 2019 Jun; 9(1):8305. PubMed ID: 31165753
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF
BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T
BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084
[TBL] [Abstract][Full Text] [Related]
10. Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival.
Grunewald CM; Henn A; Galsky MD; Plimack ER; Harshman LC; Yu EY; Crabb SJ; Pal SK; Alva AS; Powles T; De Giorgi U; Agarwal N; Bamias A; Ladoire S; Necchi A; Vaishampayan UN; Sternberg CN; Bellmunt J; Baniel J; Niegisch G
Urol Oncol; 2020 Dec; 38(12):934.e1-934.e9. PubMed ID: 32660788
[TBL] [Abstract][Full Text] [Related]
11. Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients.
Zhang ZL; Dong P; Li YH; Liu ZW; Yao K; Han H; Qin ZK; Zhou FJ
Chin J Cancer; 2014 Mar; 33(3):165-71. PubMed ID: 23958053
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort.
Pouessel D; Bastuji-Garin S; Houédé N; Vordos D; Loriot Y; Chevreau C; Sevin E; Beuzeboc P; Taille A; Le Thuaut A; Allory Y; Culine S
Clin Genitourin Cancer; 2017 Feb; 15(1):e45-e52. PubMed ID: 27554584
[TBL] [Abstract][Full Text] [Related]
13. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
[TBL] [Abstract][Full Text] [Related]
14. Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer.
Park E; Ha HK; Chung MK
Int Urol Nephrol; 2011 Dec; 43(4):1059-65. PubMed ID: 21626133
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
Guzzo TJ; Resnick MJ; Canter DJ; Balandra A; Bergey MR; Magerfleisch L; Tomaszewski JE; Vaughn DJ; Malkowicz SB
Can J Urol; 2010 Dec; 17(6):5465-71. PubMed ID: 21172112
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer.
Kanatani A; Nakagawa T; Kawai T; Naito A; Sato Y; Yoshida K; Nozaki K; Nagata M; Yamada Y; Azuma T; Suzuki M; Fujimura T; Fukuhara H; Nishimatsu H; Kume H; Igawa Y; Homma Y
Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
[TBL] [Abstract][Full Text] [Related]
18. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
Soloway MS; Lopez AE; Patel J; Lu Y
Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219
[TBL] [Abstract][Full Text] [Related]
19. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR; Ballas LK; Niemierko A; Lajkosz K; Kuk C; Miranda G; Drumm M; Mari A; Thio E; Fleshner NE; Kulkarni GS; Jewett MAS; Bristow RG; Catton C; Berlin A; Sridhar SS; Schuckman A; Feldman AS; Wszolek M; Dahl DM; Lee RJ; Saylor PJ; Michaelson MD; Miyamoto DT; Zietman A; Shipley W; Chung P; Daneshmand S; Efstathiou JA
Lancet Oncol; 2023 Jun; 24(6):669-681. PubMed ID: 37187202
[TBL] [Abstract][Full Text] [Related]
20. Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement.
Stöckle M; Wellek S; Meyenburg W; Voges GE; Fischer U; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
Urology; 1996 Dec; 48(6):868-75. PubMed ID: 8973669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
